BeOne Medicines
ONC
#769
Rank
C$44.48 B
Marketcap
C$428.77
Share price
0.20%
Change (1 day)
30.73%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Annual Reports (10-K)

Latest form 10-K annual reports for BeOne Medicines CIK: 0001651308

Thumbnail BeOne Medicines 10-K Annual Report

10-K Annual Report 2026-02-26

Language: English

View Annual Report (10-K)
Thumbnail BeOne Medicines 10-K Annual Report

10-K Annual Report 2025-02-27

Language: English

View Annual Report (10-K)
Thumbnail BeOne Medicines 10-K Annual Report

10-K Annual Report 2024-02-26

Language: English

View Annual Report (10-K)
Thumbnail BeOne Medicines 10-K Annual Report

10-K Annual Report 2023-02-27

Language: English

View Annual Report (10-K)
Thumbnail BeOne Medicines 10-K Annual Report

10-K Annual Report 2022-02-28

Language: English

View Annual Report (10-K)
Thumbnail BeOne Medicines 10-K Annual Report

10-K Annual Report 2021-02-25

Language: English

View Annual Report (10-K)
Thumbnail BeOne Medicines 10-K Annual Report

10-K Annual Report 2020-03-02

Language: English

View Annual Report (10-K)
Thumbnail BeOne Medicines 10-K Annual Report

10-K Annual Report 2019-02-28

Language: English

View Annual Report (10-K)
Thumbnail BeOne Medicines 10-K Annual Report

10-K Annual Report 2018-02-28

Language: English

View Annual Report (10-K)
Thumbnail BeOne Medicines 10-K Annual Report

10-K Annual Report 2017-03-22

Language: English

View Annual Report (10-K)
Thumbnail BeOne Medicines 10-K Annual Report

10-K Annual Report 2016-03-30

Language: English

View Annual Report (10-K)